KALVISTA PHARMACEUTICALS INC shareholders Q2 2023

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 96 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.

KALVISTA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MILLENNIUM MANAGEMENT LLC 27,935$251,4150.00%
PRICE T ROWE ASSOCIATES INC /MD/ 32,516$2930.00%
NEW YORK STATE COMMON RETIREMENT FUND 508$50.00%
NISA INVESTMENT ADVISORS, LLC 4,339$39,0510.00%
DEUTSCHE BANK AG\ 9,387$84,4830.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 65,154$586,3860.00%
MORGAN STANLEY 202,623$1,823,6070.00%
ACADIAN ASSET MANAGEMENT LLC 8,736$780.00%
AMALGAMATED BANK 2,324$210.00%
BlackRock Inc. 1,599,738$14,397,6420.00%
Bank of New York Mellon Corp 82,801$745,2090.00%
Citadel Advisors 600$5,4000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 31,600$284,4000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 106,500$958,5000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 59,971$539,7390.00%
Nuveen Asset Management, LLC 61,783$556,0470.00%
SIMPLEX TRADING, LLC 1,290$110.00%
Crewe Advisors LLC 14$1260.00%
Financial Gravity Asset Management, Inc. 9$100.00%
Lindbrook Capital, LLC 0$00.00%
External links

This page lists KALVISTA PHARMACEUTICALS INC's shareholders in Q2 2023. To view KALVISTA PHARMACEUTICALS INC's shareholder history, click here.